What are the director's duties to destory the negative sides of the conflicts
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
The sources of conflicts at schools should be analyzed well and managers should fullfill their duties properly in order to eliminate the negative effects of these conflicts. The organization manager should analyze the reasons of the conflicts instead of indifference in the area of conflict and minimize these negative effects. Otherwise, the polarizations will increase at the institution and the good atmosphere will be spoiled. This event will cause the retrogress of the institution, unproductiveness and decreasing of the success of the institution. A manager should turn this conflict from negative into positive in order to keep the benefits of institution at the highest level and eliminate the negative atmosphere occurring at the institution. This research was prepared in order to be a guide for managers to manage their institutions in a good way and to determine the duties of managers in order to eliminate the conflicts in working process.
Author
Emircan Ünlü
Institution
How to Cite
Emircan Ünlü (Master Thesis). What are the director's duties to destory the negative sides of the conflicts, 2012, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)